2 completed, 2 unknown, 1 recruiting. 2 Phase 4, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 1, Unknown 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow S 5682: new trials by email Literature Review of S 5682 trials Research Report on S 5682
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dimotec (Diosmin) 1000 mg Film Coated Tablet Fed Study Dimotec 1000 mg film-coated tablet, Detralex 1000 mg film-coated tablets - Healthy Volunteers | Phase 1 | Recruiting | Keri Pharma Hungary Kft | 72 | 2026-06-29 | 2026-09-09 |
| Phase 4 Study to Evaluate Efficacy and Safety of Entelon Tab.150mg in Patients With Chronic Venous Disease(CVD) Entelon Tab.150mg, Venitol Tab., Placebo of Venitol Tab. - Chronic Venous Disease | Phase 4 | Unknown | Hanlim Pharm. Co., Ltd. | 278 | 2021-01-28 | 2021-05-11 |
| The Efficacy and Safety of Different Phlebotonic Drugs in Children With Venous Malformations Detralex, Troxevasin - Drug Effect, Children, Only | Unknown | Center for Vascular Pathology, Moscow | 1000 | 2019-09-17 | 2021-11-09 | |
| Data on the Impact of Different Treatment on the Quality of Life of Patients With Acute and Chronic Hemorrhoid Disease Hemorrhoidectomy, Thrombectomy , Operation on Longo method, Detralex, Combined therapy - Hemorrhoids | Completed | Servier Russia | 1032 | 2019-03-01 | 2021-03-29 | |
| Study of Antiinflammatory Effects of Detralex (Daflon) Detralex - Chronic Venous Insufficiency | Phase 4 | Completed | University Hospital Dubrava | 84 | 2012-08-01 | 2019-11-01 |
Hemorrhoids (1) · Inflammation (1) · Varicose Veins (1) · Vascular Malformations (1)
Center for Vascular Pathology, Moscow (1) · Hanlim Pharm. Co., Ltd. (1) · Keri Pharma Hungary Kft (1) · Servier Russia (1) · University Hospital Dubrava (1)
Russia (2) · Croatia (1) · India (1) · South Korea (1)
Dmitriy Romanov, MD (1) · Ekaterina Listovskaia, MD (1) · Marko Ajduk, PhD (1) · Sharath Reddy A, MBBS (1)